Chapter 38 Aminoglycosides

Slides:



Advertisements
Similar presentations
All the following are antibiotics used for gram –ve bacteria.
Advertisements

MACROLIDES Erythromycin Clarithromycin Azithromycin Mechanism of action Inhibit protein synthesis by binding to the 50 s subunit Antibacterial activity.
AMINOGLYCOSIDES Streptomycin* Gentamicin* Tobramycin* Amikacin Kanamycin Neomycin(topical) * most commonly used Antibacterial Spectrum Bactericidal ( exclusive.
PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Aminoglycosides Mark Johnson, Pharm.D., BCPS
Β-Lactam antibiotics. Classification Penicillins Cephalosporins Other β-Lactam drugs Cephamycins (头霉素类) Carbapenems (碳青霉烯类) Oxacephalosporins (氧头孢烯类)
Drugs acting on bacterial protein biosynthesis
Chapter 37 Aminoglycosides( 氨基糖苷类 ) & Polymyxins( 多黏菌素类 ) Huifang Tang
Chapter 37 Aminoglycosides
Macrolides, Lincomycins
Macrolides, Lincomycins &Vancomycins Section 3 Yun-Bi Lu, PhD 卢韵碧 Dept. of Pharmacology, School of Medicine, Zhejiang University
 At the end of the lecture, students should :  Describe briefly common types of meningitis  Describe the principles of treatment  List the name of.
Chapter 40 Aminoglycosides and Polymyxins Department of pharmacology Liu xiaokang( 刘小康) 2010,3.
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.
Aminoglycosides All aminoglycosides are produced by soil actinomycetes. Obtained from the species of – Streptomyces (suffix mycin) – and Micromonospora.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 86 Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis.
2. Antibiotics - Aminoglycosides Pharmacognosy IV PHG 423 Dr/ Abdulaziz Saeedan Pharmacy College 1.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Antimicrobials acting on ribosome
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
Treatment Of Respiratory Tract infections. Prof. Azza ELMedany Department of Pharmacology Ext
INHIBITOR of BACTERIAL PROTEIN SYNTHESIS. BACTERIAL PROTEIN SYNTHESIS The selectivity for bacterial protein synthesis is caused by differences in the.
Treatment of Respiratory Tract infections. Prof. Azza EL-Medany.
PRINCIPLES OF ANTIBIOTIC THERAPY
Among the many antibiotics isolated from that genus, several are compounds closely related in structure to streptomycin. Six of them kanamycin, neomycin,
Aminoglycosides Antibiotics Dr. yasodha krishna janapati Associate Professor Dept. of Pharmaceutical Chemistry, College of Health Sciences (CHS), Ayder Campus, Mekelle University, Mekelle, ETHIOPIA Introduction: Aminoglycos
Antibiotics By Alaina Darby.
Antibiotics By Alaina Darby.
More Antibiotics Tutoring for Pharmacology
Protein Synthesis Inhibitors
AMINOGLYCOSIDES.
Antimicrobials acting on ribosome
Protein Synthesis Inhibitors
Miscellaneous Antibiotics
4. Antibiotics - Polymyxins (Polypeptides)
Aminoglycosides.
Natural antibiotics III
By :Lecturer Nabeel Ahmed Al anbagi
Drugs used in Meningitis Prof. Azza ELMedany
Vancomycin Vancomycin has become increasingly important in the treatment of life-threatening infections. MRSA infections. Methicillin-resistant Staphylococcus.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Pencillins.
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Cell Wall Synthesis Inhibitors (Penicillins)
Course Coordinator Jamaluddin Shaikh, Ph.D.
Surgical Infection Society Resident Corner
Cephalosporin and Cell Wall Synthesis Inhibitors
Aminoglycosides.
The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey  U. Över, D. Gür, S. Ünal,
Course Coordinator Jamaluddin Shaikh, Ph.D.
Other Protein Synthesis Inhibitor
Cell Wall Synthesis Inhibitors (Penicillins)
Course Coordinator Jamaluddin Shaikh, Ph.D.
Broad-spectrum antibiotics
Cephalosporin and Cell Wall Synthesis Inhibitors
Synthetic antimicrobial drugs
Chapter 36 Macrolides Clarithromycin Azithromycin Erythromycin
Beta-lactam antibiotics
The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey  U. Över, D. Gür, S. Ünal,
Antibacterial Agents: Protein Synthesis Inhibitor Antibiotics
Treatment of Respiratory Tract Infections
Treatment of Respiratory Tract Infections
Drugs used in Meningitis Prof. M. Alhumayyd Prof. Hanan hagar
Other Protein Synthesis Inhibitor
Other β-lactam A. Carbapenems:
Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis
2- Tetracyclines Classification
Cell Wall Synthesis Inhibitors (Penicillins)
Presentation transcript:

Chapter 38 Aminoglycosides Shutcm-MBL 1

Commonly used aminoglycosides Gentamicin (庆大霉素) Streptomycin (链霉素) Amikacin ( 阿米卡星、丁胺卡那霉素) Netilmicin (奈替米星) Kanamycin (卡那霉素) Tobramycin (妥布霉素) Neomycin (新霉素) Shutcm-MBL

Pharmacokinetics 1. Oral absorption: poor (be given parenterally); be given orally to eradicate intestinal bacteria; 2. Excretion: rapidly excreted by the kidney; short half-lives; 3. Distribution: do not cross the blood-brain barrier, but they cross the placenta; Blood concentrations should be measured to guide dosing. Shutcm-MBL

Antibacterial mechanism: Spectrum of activity: 1. Active against many Gram-negative bacteria (including Pseudomonas species ) and some Gram-positive bacteria. 2. Streptomycin: Mycobacterium tuberculosis 3. Inactive against anaerobes, which are unable to take up the aminoglycosides; Antibacterial mechanism: Inhibit bacterial protein synthesis (bactericidal) 假单胞菌 结核杆菌 Shutcm-MBL

Indications: infections caused by sensitive gram-negative bacilli (urinary, respiratory, and biliary systems); Drug resistance: 1. Production of enzymes that acetylate, phosphorylate or adenylyl aminoglycosides; 2. Reduced penetration of the drug (can be overcome by co-administration of antibacterials that disrupt cell wall synthesis , such as penicillins); 3. Changes in the ribosomal proteins in bacteria; Streptomycin has cross-resistance with getamicin, kanamycin and neomycin Shutcm-MBL

Adverse reactions Ototoxicity: disturbances of balance or deafness that are often irreversible; caused by accumulation of the aminoglycoside in the inner ear. Nephrotoxicity: usually reversible; defect in the concentrating ability of the kidney, with mild proteinuria followed by a reduction in the glomerular filtration rate; caused by retention of aminoglycosides in the proximal tubular cells of the kidney; Neuromuscular blockade: usually occurs when used with anesthetic drugs; Allergic reactions Shutcm-MBL

Gentamycin [,dʒentə‘maisin] 庆大霉素 Uses: 1. Infection by gram-negative bacilli 2. Pseudomonas aeruginosa: in combination with carbencillin; 3. bacterial endocarditis: with penicillin 4. Polyinfection: with cephalosporin or carbencillin ; 5. Oral: bowel infection, helicobacter pylori ulcer. 绿脓杆菌 羧苄西林 幽门螺杆菌溃疡 Shutcm-MBL

Streptomycin Uses: pestis , tuberculosis (second line) Amikacin Uses: Infection by gram-negative bacilli more resistant to modifying enzyme Shutcm-MBL